Literature DB >> 9748293

Myocyte enhancer factor-related B-MEF2 is developmentally expressed in B cells and regulates the immunoglobulin J chain promoter.

S Rao1, S Karray, E R Gackstetter, M E Koshland.   

Abstract

Immunoglobulin J chain gene expression is induced by the delivery of a lymphokine signal to antigen-activated B cells in a primary immune response. A major interleukin 2 (IL-2)-responsive region that contains two adjacent control elements (JA and JB) exists within the J chain promoter. Transcription factor PU.1 positively regulates J chain gene expression by binding to one of the control elements (JB) in the J chain promoter. In the present study we have determined that a myocyte enhancer factor 2 (MEF2)-related nuclear factor, named B-MEF2, positively regulates the J chain gene promoter activity via the second control element (JA). An in vitro translated MEF2 family member, MEF2C, was found to bind the JA site with identical properties as endogenously expressed B-MEF2 in B cell lines. Moreover, in vivo experiments showed that a dominant negative mutant of MEF2C blocked B-MEF2 regulation of the J chain promoter. Consistent with its role as positive regulator of J chain gene expression, B-MEF2 levels were enhanced in highly differentiated B cells. In addition, induction of an IL-2-responsive presecretor cell line BCL1 with IL-2 or IL-5 (which up-regulates J chain gene expression) resulted in an increased expression of B-MEF2. We conclude that a MEF2-related transcriptional factor, B-MEF2, acts as a stage-specific positive regulator of J chain gene expression in the B cell lineage.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9748293     DOI: 10.1074/jbc.273.40.26123

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Re-employment of developmental transcription factors in adult heart disease.

Authors:  Toru Oka; Jian Xu; Jeffery D Molkentin
Journal:  Semin Cell Dev Biol       Date:  2006-11-24       Impact factor: 7.727

2.  Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c.

Authors:  Sandra Stehling-Sun; Jessica Dade; Stephen L Nutt; Rodney P DeKoter; Fernando D Camargo
Journal:  Nat Immunol       Date:  2009-01-25       Impact factor: 25.606

3.  Ligament versus bone cell identity in the zebrafish hyoid skeleton is regulated by mef2ca.

Authors:  James T Nichols; Bernardo Blanco-Sánchez; Elliott P Brooks; Raghuveer Parthasarathy; John Dowd; Arul Subramanian; Gregory Nachtrab; Kenneth D Poss; Thomas F Schilling; Charles B Kimmel
Journal:  Development       Date:  2016-10-27       Impact factor: 6.868

Review 4.  Putting J chain back on the map: how might its expression define plasma cell development?

Authors:  Caitlin D Castro; Martin F Flajnik
Journal:  J Immunol       Date:  2014-10-01       Impact factor: 5.422

5.  Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation.

Authors:  Peter R Wilker; Masako Kohyama; Michelle M Sandau; Jörn C Albring; Osamu Nakagawa; John J Schwarz; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2008-04-27       Impact factor: 25.606

6.  Vertebrate paralogous MEF2 genes: origin, conservation, and evolution.

Authors:  Wenwu Wu; Stefan de Folter; Xia Shen; Wenqian Zhang; Shiheng Tao
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

Review 7.  The B-cell system of human mucosae and exocrine glands.

Authors:  P Brandtzaeg; I N Farstad; F E Johansen; H C Morton; I N Norderhaug; T Yamanaka
Journal:  Immunol Rev       Date:  1999-10       Impact factor: 12.988

8.  Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk.

Authors:  Theresa Tretter; Ashley E Ross; Dominic I Dordai; Stephen Desiderio
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

Review 9.  MEF2 transcription factors: developmental regulators and emerging cancer genes.

Authors:  Julia R Pon; Marco A Marra
Journal:  Oncotarget       Date:  2016-01-19

10.  MEF2B mutations in non-Hodgkin lymphoma dysregulate cell migration by decreasing MEF2B target gene activation.

Authors:  Julia R Pon; Jackson Wong; Saeed Saberi; Olivia Alder; Michelle Moksa; S-W Grace Cheng; Gregg B Morin; Pamela A Hoodless; Martin Hirst; Marco A Marra
Journal:  Nat Commun       Date:  2015-08-06       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.